Scientific Program 12th Edition

Download the page_white_acrobat SYMPOSIUM PROGRAM

THURSDAY, 28th May 2015

THURSDAY, 28th May 2015
8.00 – 9.00 REGISTRATION
9.00 – 9.30 WELCOMING
9.30 – 10.30 OPENING LECTURES
CHALLENGES IN REGENERATIVE CARDIOVASCULAR MEDICINEChairs: John Martin (London, UK)
Andreas Zeiher (Frankfurt, Germany)
9.30 – 9.50 Learning from development
Nadia Rosenthal (Melbourne, Australia)
9.50 – 10.10 Cardiac Regeneration: Evolving from Principles to Practice
André Terzic (Rochester, USA)
10.10 – 10.30 Is there a role for cardiac regeneration in advanced heart disease? Overcoming frontiers to move forward.
Valentin Fuster (New York, USA)
10:30 – 12:00 CARDIOVASCULAR REGENERATIVE MEDICINE. CRISIS, WHAT CRISIS?

Chairs: José Luís de la Serna (El Mundo Salud) (Madrid, Spain)
Francisco Fernández-Avilés (Madrid, Spain)

Panel Discussants: Timothy Henry (Los Angeles, USA)
Dominique Charron (Paris, France)
Stefanie Dimmeler (Frankfurt, Germany)
André Terzic (Rochester, USA)

10.30 (12’) Importance of the cells. What are we using?
Piero Anversa (Boston, USA)
10.42 (12’) Can we improve the regenerative power of transplanted or native cells? Proteins, genes, what else?
Atta Behfar (Rochester, USA)
10.54 (12’) First-in-man cardiac transplantation of human embryonic stem cell-derived cardiac progeny tors for severe heart failure
Philippe Menasché (Paris, France)
11.06 (12’) Lights and shadows of clinical trials. Should we continue? In which setting? How?
Bernard Gersh (Rochester, USA)
11.18 (12’) Cell based therapies to prevent and cure heart failure. More than an adventure?
Douglas W. Losordo (Boston, USA)
11.30 (12’) Cardiac regenerative medicine beyond scientists and clinicians. Are we doing well?
John Martin (London, UK)
11.42 – 12.00 Panel Discussion
12:00 – 12:45 LUNCH AND POSTER EXHIBITION

Chairs and jury: Philippe Menasche (Paris, France)
Felipe Prosper (Pamplona, Spain)

In this “Poster Exhibition”, research teams involved in the topic of the Symposium will have the opportunity of presenting selected parts of their work to the audience.
The Poster Review Committee will select which the best posters of the session are. At the end of the session, the verdict will be communicated. The winners of the Posters Awards will have to present their work (oral pres-entation) the following day in the morning, in the session named “Best Poster Presentation”, when they will receive their prize.

For more information regarding Poster Exhibition and Poster Awards, please contact us via e-mail at
posters@cardiovascularcelltherapy.com

12:45 – 14:45 WHAT’S NEW IN STEM CELL THERAPY FOR CARDIAC REPAIR?

Chairs : Timothy Henry (Los Angeles, USA)
André Terzic (Rochester, USA)

Panel Discussants: Roberto Fdez-Viña (Buenos Aires, Argentina)
Kai C. Wollert (Germany)
Stefan Janssens (Leuven, Belgium)
Jerome Roncalli (Toulouse, France)

12.45 (12’) Beyond myocardium. Cardiac valve repair.
Amir Lerman (Rochester, USA)
12.57 (12’) What´s new in induced pluripotent stem cells.
Eric A. Adler (San Diego, USA)
13.09 (12’) Combinations of stem cells. Which ones to choose?
Joshua Hare (Miami, USA)
13.21 (12’) Role of cardiopoiesis in the second-generation stem cells´ era.
Almudena Martínez-Fernández (Rochester, USA)
13.33 (12’) Cell based therapies: Novel developments in the arena of delivery strategy
Steven Chamuleau (Utrecht, The Netherlands)
13.45 (12’) Stemless biological therapies for cardiac repair.
Stefanie Dimmeler (Frankfurt, Germany)
13.57 (12’) Latest clinical news: the Dream-HF experience
Emerson Perin (Houston, USA)
14.09 (12’) Future clinical news: Trials in perspective
Thomas J. Povsic (Durham, USA)
14.21 – 14.45 Panel Discussion
14.45 – 15.15 Coffee break and poster exhibition
15.15 – 15.25 Posters Award – Winners communication
Chairs: Philippe Menasché (Paris, France)
Felipe Prosper (Pamplona, Spain)
15.25 – 17.35 THIS YEAR WE DEBATE

Chairs: Bernard Gesh (Rochester, USA)
Pedro Luís Sánchez (Salamanca, Spain)

Panel discussants: Andreas Zeiher (Frankfurt, Germany)
Timothy Henry (Los Angeles, USA)
Philippe Menasché (Paris, France)
Andreu Climent (Madrid, Spain)
André Terzic (Rochester, USA)

15.25-16.16
The Clinical Debate: Why meta-analyses are contradictory
15.25 (12’) Meta-analyses and systematic reviews´ results on hold. Factual discrepancies.
Darrel Francis (London, UK)
15.37 (12’) How individual patient data change messages. The ACCRUE experience
Maryann Gyongyosi (Vienna, Austria)
15.49 (12’) Meta-analyses and systematic reviews´ results are valid and still offering evidences.
Enca Martin Rendon (Oxford, UK)
16.01 – 16.16 Discussion
16.16-16.55
How to improve: the cardiac stem cells debate
16.16 (12’) Native and enhanced CSC are the real workhorse cells.
Mark A. Sussman. (San Diego, USA)
16.28 (12’) Do we really know what CSC are and how to use them?
Bernardo Nadal-Ginard (London, UK)
16.40 – 16.55 Discussion
16.55-17.34
How to improve: The bioengineering debate: matrixes and scaffolds.
16.55 (12’) Bioartificial matrixes. Available and versatile.
Felipe Prosper (Pamplona, Spain)
17.07 (12’) Cadaveric matrixes. Native myocardial architecture is mandatory.
Doris Taylor (Houston, USA)
17.19 – 17.34 Discussion

FRIDAY, 29th May 2015

FRIDAY, 29th May 2015
9.00 – 9.30 BEST POSTER PRESENTATION

Chairs: Philippe Menasche (Paris, France)
Felipe Prosper (Pamplona, Spain)

9.30 – 10.30 RECENT CONTRIBUTIONS PRESENTED BY YOUNG INVESTIGATORS

Chairs: Philippe Menasche (Paris, France)
Felipe Prosper (Pamplona, Spain)

Panel discussants: Atta Behfar (Rochester, USA)
Javier Bermejo (Madrid, Spain)
Joshua Hare (Miami, USA)
Stefan Janssens (Leuven, Belgium)

9.30 – 9.40 Cardioprotection by telomerase treatment
Christian Bar (Maria Blasco’s group. Madrid, Spain)
9.40 – 9.50 Natura killer cell crosstalk with allogenic human cardiac-derived stem/progenitor cells control persistence
Reem Al Daccak (Dominique Charron’s group. Paris, France)
9.50 – 10.00 Myocardial infarct scar is formed by interacting resident epicardial-derived fibroblastsand recruited bone marrow cells
Adrian Ruiz Villalba (Felipe Prosper’s group. Pamplona, Spain)
10.00 – 10.10 Novel CMR based techniques to detect cardiac fibrosis
Johannes M.I.H. Gho (Steven Chamuleau’s group. Utrecht, The Netherlands)
10.10 – 10.30 Panel Discussion
10.30- 11.00 Coffee Break
11.00 – 12.45 DISCOVERIES AND INVENTIONS

Chairs: Dominique Charron (Paris, France)
Alberto San Román (Valladolid, Spain)

Panel discussants: Juan Carlos Chachques (Paris, France)
Raquel Yotti (Madrid, Spain)
Angel Arenal (Madrid, Spain)
Giulio Pompilio (Milan, Italy)

11.00 – 11.20 Genes and cells to fight against pulmonary hypertension.
Duncan Stewart (Otawa, Canada)
11.20 – 11.40 High-density optical mapping in a monolayer of iPSC-derived cardiomyocytes as a tool for understanding arrhythmic disorders.
Andreu M. Climent (Madrid, Spain)
11.40 – 12.00 Patient-specific stem cell manufacturing for the development of dedicated cardiovascular drugs.
Joseph Wu (Stanford , USA)
12.00 – 12.20 Bioprosthetic Carmat Total Artificial Heart: from a dream to the first-in-human implantation.
Christian Latremouille (Paris, France)
12.20 – 12.45 Panel Discussion
12.45– 13.30 Break
13.30 – 13.50 SPECIAL LECTURE

Chairs: Rafael Matesanz (Madrid, Spain)
Arturo Fdez-Cruz (Madrid, Spain)

Interspecies genetic manipulation for organ manufacturing. What about the heart?
Juan Carlos Izpisua (La Jolla, USA)

13.50– 14.20 CLOSING SESSION
SECOND MADRID CARDIAC REGENERATION AWARDSChairs: John Martin (London, UK)
Rafael Matesanz (Madrid, Spain)
14.20 ADJOURN
Francisco Fdez-Aviles (Madrid, Spain)
Konstantinos Malliaras
(Eduardo Marban’s group. Los Angeles, USA)